AbstractInduction of non-specific toxicities by doxorubicin (DOX) has restricted conventional DOX-based chemotherapy. pH-responsive dextrin nanogels (DNGs) have been fabricated in order to incorporate and deliver DOX to specific (targeted) sites. However, adequate stability studies of DOX-loaded DNGs are required for selection of storage conditions. The aim of this study was therefore to evaluate the accelerated (25 °C/60% RH) and long-term (5 °C) stability of DNGs prepared with formaldehyde (FDNGs) and glyoxal (GDNGs) as cross-linker by determining the change in their physicochemical properties. The mean diameter decreased with time during long-term storage. The drug content between freshly prepared (initial day) and after storage at 5 °C ...
Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limi...
Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limi...
Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limi...
AbstractInduction of non-specific toxicities by doxorubicin (DOX) has restricted conventional DOX-ba...
© 2016 The Authors. Induction of non-specific toxicities by doxorubicin (DOX) has restricted convent...
Induction of non-specific toxicities by doxorubicin (DOX) has restricted conventional DOX-based chem...
The aim of this study was to develop pH-responsive dextrin nanogels (DNGs) capable of triggered intr...
Efficacy of doxorubicin (DOX) in colorectal cancer treatment is limited by undesirable side-effects,...
Three derivatives of doxorubicin (DOX) were prepared by modifying DOX with succinic anhydride, cisac...
The use of smart nanocarriers that can modulate therapeutic release aided by biological cues can pre...
The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids...
The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids...
The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids...
Nanocarriers can significantly improve the therapeutic index of drug in cancer therapy. At present, ...
Ying Fang,1,* Hao Wang,2,* Hong-Jing Dou,2,* Xing Fan,1,* Xiao-Chun Fei,3 Lei Wang,2 Shu Cheng,1 Ann...
Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limi...
Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limi...
Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limi...
AbstractInduction of non-specific toxicities by doxorubicin (DOX) has restricted conventional DOX-ba...
© 2016 The Authors. Induction of non-specific toxicities by doxorubicin (DOX) has restricted convent...
Induction of non-specific toxicities by doxorubicin (DOX) has restricted conventional DOX-based chem...
The aim of this study was to develop pH-responsive dextrin nanogels (DNGs) capable of triggered intr...
Efficacy of doxorubicin (DOX) in colorectal cancer treatment is limited by undesirable side-effects,...
Three derivatives of doxorubicin (DOX) were prepared by modifying DOX with succinic anhydride, cisac...
The use of smart nanocarriers that can modulate therapeutic release aided by biological cues can pre...
The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids...
The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids...
The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids...
Nanocarriers can significantly improve the therapeutic index of drug in cancer therapy. At present, ...
Ying Fang,1,* Hao Wang,2,* Hong-Jing Dou,2,* Xing Fan,1,* Xiao-Chun Fei,3 Lei Wang,2 Shu Cheng,1 Ann...
Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limi...
Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limi...
Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limi...